Cipla plans to focus more on new chemical entities
Cipla is growing beyond generics and is seeing opportunities well beyond. In a rare interview to NDTV Profit, Dr Yusuf Hamied, chairman, Cipla, revealed a broadening focus and the possibility of venturing into new areas.
